Donate during COVID-19
Tufts Medical Center in Boston has been providing world-class care for cancer patients since the 1940s. During that time, cancer treatment and research have become increasingly complex.
We founded the Experimental Therapeutics Program at Tufts MC to accelerate the discovery and delivery of new cancer therapies. Our program consolidates cancer research at Tufts MC so that our experts can easily share information and ideas with one another. In addition, our six state-of-the-art laboratory facilities provide access to the technology our researchers need to develop groundbreaking new treatments.
We focus our research efforts on:
If you've recently been diagnosed with cancer, you want to know you're getting the most effective care right from the start. Or, you may have already tried standard cancer treatments and are now looking for new options. Either way, our program can efficiently connect you with the care you need.
In the Experimental Therapeutics Program, physician researchers work side-by-side with laboratory scientists. This enables us to quickly take discoveries "from bench to bedside." As a patient, you'll feel confident that our team is offering you access to the latest therapies and the most promising clinical trials.
Participating departments at Tufts University include the:
Title(s): Clinical Director, Tufts Cancer Center; Professor, Tufts University School of Medicine Department(s): Medicine, Hematology/Oncology Appt. Phone: 617-636-5757 Fax #: 617-636-7060
Breast cancer, clinical trials
Accepting New Patients
Title(s): Genitourinary Oncologist; Associate Professor, Tufts University School of Medicine Department(s): Medicine, Hematology/Oncology Appt. Phone: 617-636-6227 Fax #: 617-636-8538
Clinical care of genitourinary cancers with a special emphasis on prostate cancer, modeling bone metastases and experimental therapeutics in prostate cancer and other genitourinary malignancies
In the Experimental Therapeutics Program, we value our relationships with referring physicians, and we're committed to working with you to bring novel therapies to your cancer patients.
